SCHEMBL21168473

SCHEMBL21168473

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccccc3-c3ccccc3N(c3ccc(-c4ccccc4)cc3)c3ccc4c5ccccc5c5ccccc5c4c3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ PTBP1 P26599 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GALK1 P51570 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ SMAD3 P84022 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CRHR1 P34998 1/20 0.31
▸ HPRT1 P00492 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22259397 1.00 MEN1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL24029649 0.95 CRHR1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL24029642 0.95 CRHR1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL24029644 0.95 CRHR1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL21764381 0.95 CRHR1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL15306214 0.94 CRHR1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL15306212 0.92 CRHR1 (0.32) MEN1APAF1NPC1LMNAMAPT
SCHEMBL24029669 0.91 MCL1 (0.39) MEN1MAPTKMT2AATMSMN1; SMN2
SCHEMBL17816616 0.90 MEN1 (0.33) MEN1APAF1NPC1LMNAMAPT
SCHEMBL26341395 0.90 MEN1 (0.32) MEN1MAPTKMT2AATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200231534-A1 ARYLDIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2020-07-23 — — US disclosed
EP-3511316-A1 ARYLDIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2019-07-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200231534-A1 ARYLDIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT FTO, SLC19A1, ALKBH1 MEN1 2873/4885APAF1 1952/4885NPC1 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback